M2d macrophages, also known as tumor-associated macrophages (TAMs), are induced by the TLR antagonists, and they release IL-10, TGF-βand vascular endothelial growth factors (VEGF) to contribute to tumor angiogenesis (17–21) (Figure 1). The gene discussed is VEGFA; the disease is neoplasm.